Analyst Price Targets — ZIVO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 4, 2024 7:54 am | Anthony Vendetti | Maxim Group | $12.00 | $7.96 | StreetInsider | Maxim Group Downgrades ZIVO Bioscience, Inc. (ZIVO) to Hold |
Latest News for ZIVO
Financial Survey: ZIVO Bioscience (NASDAQ:ZIVO) versus Finch Therapeutics Group (NASDAQ:FNCH)
Earnings and Valuation This table compares Finch Therapeutics Group and ZIVO Bioscience"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Finch Therapeutics Group N/A N/A -$74.75 million ($8.82) -1.53 ZIVO Bioscience $15,850.00 2,464.05 -$7.78 million ($2.18) -4.55 ZIVO Bioscience has higher revenue and earnings than
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ZIVO.
U.S. House Trading
No House trades found for ZIVO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.